FDC

FDC Limited

FDC Limited (FDC) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹356.25
Market cap
5,798 Cr
Stock P/E
19.8
P/B
2.33
Dividend yield
1.4%
ROE (FY26)
11.3%
ROCE (FY26)
15.3%
Operating margin (FY26)
13.2%
OCF / EBITDA (FY26)
57.9%
OCF / EBITDA (3Y)
73.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

FDC makes and sells branded medicines in India, mainly oral rehydration salts (ORS), anti-infectives and eye-care (ophthalmic) products, and also exports formulations and sells active pharmaceutical ingredients (APIs).

Company snapshot

57thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Interest coverage of 57.5x — earnings comfortably cover interest obligations.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales486 Cr458 Cr462 Cr638 Cr514 Cr464 Cr492 Cr648 Cr473 Cr465 Cr585 Cr668 Cr
Operating expenses (approx.)410 Cr374 Cr406 Cr492 Cr444 Cr417 Cr438 Cr508 Cr439 Cr412 Cr478 Cr525 Cr
EBITDA76 Cr84 Cr56 Cr147 Cr70 Cr47 Cr54 Cr140 Cr34 Cr52 Cr106 Cr143 Cr
OPM %15.7%18.3%12.2%23.0%13.7%10.1%11.0%21.6%7.1%11.2%18.2%21.4%
Other income27 Cr25 Cr20 Cr28 Cr35 Cr19 Cr16 Cr36 Cr21 Cr21 Cr50 Cr48 Cr
Interest1 Cr0.97 Cr0.95 Cr1 Cr1 Cr0.95 Cr1 Cr1 Cr1 Cr1 Cr2 Cr0.83 Cr
Depreciation10 Cr10 Cr10 Cr11 Cr14 Cr13 Cr16 Cr15 Cr15 Cr15 Cr14 Cr15 Cr
Profit before tax93 Cr98 Cr65 Cr163 Cr90 Cr51 Cr53 Cr160 Cr38 Cr36 Cr140 Cr175 Cr
Tax %24.7%18.8%29.0%26.9%20.0%27.6%27.5%24.0%25.5%22.2%26.3%24.2%
Net profit70 Cr79 Cr46 Cr119 Cr72 Cr37 Cr39 Cr121 Cr28 Cr28 Cr103 Cr132 Cr
EPS (₹)₹4.22₹4.86₹2.84₹7.31₹4.43₹2.28₹2.38₹7.45₹1.75₹1.74₹6.35₹8.14

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,051 Cr1,083 Cr1,091 Cr1,344 Cr1,333 Cr1,528 Cr1,784 Cr1,943 Cr2,108 Cr2,171 CrSign in free for the trailing twelve months
Operating expenses (approx.)808 Cr856 Cr860 Cr1,051 Cr999 Cr1,274 Cr1,533 Cr1,604 Cr1,783 Cr1,825 CrSign in free for the trailing twelve months
EBITDA243 Cr227 Cr231 Cr293 Cr334 Cr254 Cr251 Cr339 Cr325 Cr346 CrSign in free for the trailing twelve months
OPM %23.2%20.9%21.2%21.8%25.1%16.6%14.1%17.4%15.4%15.9%Sign in free for the trailing twelve months
Other income50 Cr51 Cr43 Cr69 Cr97 Cr76 Cr50 Cr102 Cr91 Cr114 CrSign in free for the trailing twelve months
Interest1 Cr1 Cr1 Cr3 Cr3 Cr3 Cr4 Cr4 Cr5 Cr5 CrSign in free for the trailing twelve months
Depreciation35 Cr35 Cr33 Cr37 Cr38 Cr37 Cr39 Cr40 Cr54 Cr59 CrSign in free for the trailing twelve months
Profit before tax252 Cr241 Cr237 Cr320 Cr388 Cr289 Cr258 Cr396 Cr357 Cr375 CrSign in free for the trailing twelve months
Tax %25.1%27.9%28.2%25.0%22.3%25.3%24.8%23.0%25.3%24.9%Sign in free for the trailing twelve months
Net profit189 Cr174 Cr170 Cr240 Cr301 Cr216 Cr194 Cr305 Cr267 Cr281 CrSign in free for the trailing twelve months
EPS (₹)₹10.60₹9.76₹9.74₹13.94₹17.72₹12.81₹11.66₹18.58₹16.39₹17.29Sign in free for the trailing twelve months
Dividend payout %————-0.4%-0.1%0.0%0.0%30.4%28.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital18 Cr18 Cr18 Cr17 Cr17 Cr17 Cr17 Cr16 Cr16 Cr16 Cr
Reserves1,252 Cr1,259 Cr1,428 Cr1,530 Cr1,717 Cr1,940 Cr1,965 Cr2,081 Cr2,265 Cr2,469 Cr
Borrowings0.69 Cr0.60 Cr0.49 Cr10 Cr0.60 Cr0.75 Cr0.64 Cr0.28 Cr0.11 Cr—
Other liabilities197 Cr227 Cr194 Cr256 Cr222 Cr313 Cr361 Cr371 Cr433 Cr434 Cr
Total liabilities1,468 Cr1,504 Cr1,640 Cr1,813 Cr1,956 Cr2,270 Cr2,343 Cr2,468 Cr2,714 Cr2,919 Cr
Fixed assets (net)671 Cr669 Cr676 Cr667 Cr670 Cr667 Cr695 Cr677 Cr848 Cr952 Cr
CWIP3 Cr10 Cr12 Cr24 Cr19 Cr105 Cr198 Cr261 Cr136 Cr96 Cr
Investments491 Cr471 Cr585 Cr665 Cr790 Cr885 Cr806 Cr843 Cr1,028 Cr1,048 Cr
Loans & advances——0.73 Cr1 Cr1 Cr0.55 Cr0.65 Cr1 Cr1 Cr0.95 Cr
Inventories137 Cr160 Cr174 Cr210 Cr215 Cr305 Cr329 Cr389 Cr375 Cr355 Cr
Trade receivables76 Cr82 Cr88 Cr124 Cr111 Cr82 Cr123 Cr117 Cr109 Cr152 Cr
Cash & bank27 Cr28 Cr20 Cr30 Cr30 Cr38 Cr24 Cr25 Cr51 Cr49 Cr
Other assets62 Cr84 Cr85 Cr92 Cr120 Cr187 Cr169 Cr155 Cr165 Cr266 Cr
Total assets1,468 Cr1,504 Cr1,640 Cr1,813 Cr1,956 Cr2,270 Cr2,343 Cr2,468 Cr2,714 Cr2,919 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity154 Cr150 Cr—250 Cr207 Cr162 Cr155 Cr221 Cr318 Cr200 Cr
Cash from investing-144 Cr20 Cr—-98 Cr-77 Cr-145 Cr11 Cr-17 Cr-200 Cr-110 Cr
Cash from financing0.35 Cr-169 Cr—-142 Cr-129 Cr-10 Cr-180 Cr-202 Cr-92 Cr-93 Cr
Net cash flow11 Cr0.52 Cr—10 Cr0.55 Cr7 Cr-14 Cr2 Cr26 Cr-3 Cr
Free cash flow (OCF − Capex)128 Cr113 Cr—219 Cr145 Cr29 Cr42 Cr127 Cr221 Cr14 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %19.9%19.0%16.5%20.8%22.6%14.9%13.2%19.1%15.9%15.3%
ROE %14.8%13.6%11.7%15.5%17.4%11.1%9.8%14.6%11.7%11.3%
Debtor days26272934302025221925
Inventory days187211211226226244204243235224
Days payable1021289412781110111116128131
Cash conversion cycle111110146133175154118149125119
OCF / EBITDA %63.5%66.1%—85.5%62.0%63.7%61.7%65.2%97.8%57.9%
OCF / EBITDA % (3 years)—————70.3%62.4%63.7%75.8%73.2%
Debt / equity0.00050.00050.00030.00620.00030.00040.00030.00010.0000—
Current ratio3.953.434.133.764.563.683.423.583.003.11
Net debt / EBITDA-0.11-0.12-0.08-0.07-0.09-0.15-0.09-0.07-0.16-0.14